PillRx only · Tablet, Coated · Oral
Eszopiclone
Brands: Lunesta · Eszopiclone
3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US8 NDCs
3 active makers
3 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.088
Latest avg · Jul 22, 2026
-5%
Since Dec 17, 2025
3
Active US suppliers
89%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
11K
Rx · 2026 Q1
309K
Units dispensed
-42%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Dr.Reddy's laboratories Limited | unknown | 13 | SUPPLYING |
| Waylis Therapeutics LLC | unknown | 3 | SUPPLYING |
| Advanced Rx of Tennessee, LLC | unknown | 2 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jun 4, 2024RECALLRecall (Class III): Eszopiclone Tablets, USP 1mg CIV, 30-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally - 500…
Failed Impurities/Degradation Specifications: Related Substances — Recalling firm: Dr. Reddy's Laboratories, Inc. — OH, MS